The invention relates to a novel
organosilicon carrier system for biological agents that is produced via a simple, stable and reproducible preparation process that is capable of maintaining
tertiary protein structure and
biological activity of the proteins and / or other biological agents in the mixture, whereby the
carrier system is obtainable by mixing one or more
organosilicon compounds, selected from the group comprising
organosilicon,
sugar organosilicon,
amino sugar organosilicon compounds, their derivatives, salts and / or the vesicles formed from them, with one or more biological agents, selected from the group comprising antigens, preantigens,
antigen conjugates, antibodies, pre-antibodies,
antibody conjugates, allergens,
allergen extracts, nucleic acids, plasmids, proteins, peptides, pharmaceutical agents, immunologically active substances and / or
cosmetics, in solution at a pH value between 7 and 8, preferably 7.4, followed by homogenisation or
sonication of the mixture, followed by
sterile filtration of the mixture, followed by lyophilisation.